Login

Mr. Nitin Verma, CEO of Mirae Asset Global Indices, unveils the future of ETFs at Innowave. 00:10:00

Share On Facebook Share On Twitter

Kim, Mi Seob · President & CEO, Mirae Asset Global Investments

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Richardson Electronics, Ltd. (NASDAQ: RELL) CEO Edward Richardson sat down with Proactive Investors at the 11th Annual LD Micro Main Event.
00:10:00
Gaining Perspective: Market Insights & Strategies Part 2 | George Smith, co-CEO and Chief Investment Officer of Smith Bruer Advisors
00:10:00
Navigating Market Uncertainty: Insights and Strategies from Wealth Management | Dr. David Ashby, Co-Founders , Mustard Seed Wealth Management.
00:10:00
First Mining Gold: Advancing Canadian Projects and Broadening Investor Base at One-to-One Conference
00:10:00
"Top Global Asset Managers Discuss the State of the Markets: A Panel with David Hunt, Cyrus Taraporevala, and Yie-Hsin Hung at the Bloomberg Invest Summit 2018"
00:00:00
Dengue fever: A Mayo Clinic expert explains the mosquito-borne infection - Stacey A. Rizza, M.D. Infectious Disease Specialist, Mayo Clinic
00:10:00
Exploration and Development of Zinc Assets in Scandinavia: Strategic Overview and Future Prospects
00:10:00
Orange Polska plans to invest up to 0.5 billion złoty this year in the development of its 5G network, including the deployment of 5G SA (stand alone) technology.
00:10:00
Epiroc and Fordia Launch 'One Face of Exploration' to Streamline Service and Products
00:10:00
Two IRA Mistakes Every Investor Should Avoid | Mike Palmer, Managing Principal , Ark Royal Wealth Management.
00:10:00
Unlocking the Secrets to Successful Retirement: A Journey of Self-Care with Freeman Linde | Freeman Linde - Certified Financial Planner of La Crosse Financial Planning Inc.
00:00:00
Eden Research hails deal with US agriscience giant Corteva as the big news they've been waiting for -Sean Smith, CEO, Eden Research

© 2026 Nehu